{"id":"W1990951986","doi":"10.1097/cji.0000000000000055","title":"Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)","year":2014,"lang":"fr","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"Amgen","keywords":"Renal cell carcinoma; Medicine; Adjuvant; Interleukin 2; Interferon; Cancer research; Oncology; Internal medicine; Cytokine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001040898,0.0002647129,0.000883122,0.0001619973,0.0001171315,0.0002799875,0.0003138064,0.0003495469,0.0007271238],"category_scores_gemma":[0.0006528473,0.0001340768,0.0003926267,0.000172307,0.0003379538,0.0002516089,0.0001800513,0.0009628481,0.0001307947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003586152,"about_ca_system_score_gemma":0.0006201072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002355514,"about_ca_topic_score_gemma":0.0008065431,"domain_scores_codex":[0.9997277,0.0001609893,0.00002189625,0.00002908979,0.0000292848,0.00003096276],"domain_scores_gemma":[0.9996941,0.0001160743,0.00009329001,0.00001912208,0.0000131699,0.00006418055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5987225,0.0256131,0.01325725,0.00222746,0.0006367512,0.0001868968,0.0001294495,0.002737066,0.03473653,0.0003018579,0.0009745314,0.3204767],"study_design_scores_gemma":[0.2108656,0.7441417,0.02425563,0.0002622575,0.00120126,0.0003778587,0.00009490668,0.003322076,0.01117206,0.0004663083,0.00381312,0.00002705098],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991851,0.00701237,0.0003739688,0.0001389565,0.00008304803,0.0002453085,0.00005302953,0.0000119975,0.0002303256],"genre_scores_gemma":[0.9955332,0.002787493,0.0006573962,0.0001777167,0.00010559,0.0003345448,0.00009533776,0.00000237229,0.0003061928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001040898,"threshold_uncertainty_score":0.005504906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01184908947618079,"score_gpt":0.2566449818555605,"score_spread":0.2447958923793797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}